New asthma injection aims to tame severe attacks

This study is testing an investigational drug called SHR-1703, given as multiple injections under the skin, to see if it is safe and effective for long-term use in adults with a specific type of severe asthma (eosinophilic asthma). Researchers will enroll about 200 participants who have had recent asthma attacks despite using standard controller medications. The main goal is to monitor side effects for about a year, while also checking if the treatment improves lung function and reduces asthma flare-ups.